Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Results (54)

    Week of November 21, 2022

    Week of November 21, 2022

    This episode discusses four MMWR reports. The first report describes the effectiveness of the updated bivalent booster in preventing COVID-19 illness. The second report examines the hospitalization rate among adults with COVID-19 who were prescribed Paxlovid. The third report describes progress toward regional measles elimination. And the last report highlights progress toward global eradication o
    December 1, 2022
    Week of October 17, 2022

    Week of October 17, 2022

    This episode discusses seven MMWR reports. The first three reports highlight the progress that's been made toward improving access to the monkeypox vaccine for those who are most affected. The fourth report looks at Monkeypox virus infection of the eye. The fifth report examines a case of monkeypox in a health care provider resulting from an occupational needlestick injury. The sixth report examin
    October 26, 2022
    Week of May 30, 2022

    Week of May 30, 2022

    This episode discusses three MMWR reports. The first report examines CDC's emergency response to a multistate monkeypox outbreak. The second report describes COVID-19 cases, hospitalizations, and deaths among Alaska Native people. And the last report highlights pediatric melatonin poisonings in the United States over the last decade.
    June 8, 2022
    Week of April 11, 2022

    Week of April 11, 2022

    This episode discusses three MMWR reports. The first report highlights COVID-19 death rates and vaccine coverage in Hong Kong during the ongoing Omicron COVID-19 outbreak. The second report examines 10 people infected with the Omicron variant within 90 days of being infected with Delta. And the last report looks at the effectiveness of mRNA vaccination after previous infection in preventing COVID-
    April 20, 2022
    Weeks of February 11th to 25th

    Weeks of February 11th to 25th

    This episode discusses nine MMWR reports. The first report looks at the effectiveness of mRNA COVID-19 vaccination among pregnant people against hospitalizations in infants younger than 6 months. The second report examines hospitalizations of children and teens with confirmed COVID-19. The next two reports look at changes in pediatric emergency department visits before and during the COVID-19 pand
    March 3, 2022
    Week of January 31, 2022

    Week of January 31, 2022

    This episode discusses five MMWR reports. The first report looks at the effectiveness of masks in indoor settings for the prevention of COVID-19. The next report looks at the clinical characteristics and outcomes of adults hospitalized with COVID-19 during Omicron and Delta predominance. The third report examines COVID-19 infection and hospitalizations by vaccination status before and during Omicr
    February 9, 2022
    Week of January 24, 2022

    Week of January 24, 2022

    This episode discusses two MMWR reports. The first report looks at trends in disease severity and health care utilization during the early Omicron variant period. And the second report looks at the effectiveness of a third dose of an mRNA vaccine in preventing COVID-19 hospitalization among adults with and without weakened immune systems.
    February 2, 2022
    Week of January 17, 2022

    Week of January 17, 2022

    This episode discusses six MMWR reports. The first report looks at racial and ethnic disparities in receipt of monoclonal antibodies for the treatment of COVID-19. The next three reports examine the protection provided by COVID-19 vaccines, including booster doses, during periods of Delta and Omicron variant emergence. The fifth report examines updated ACIP guidance for the use of Johnson & Johnso
    January 28, 2022
    Week of January 3, 2022

    Week of January 3, 2022

    This episode discusses four MMWR reports. The first report looks at the effectiveness of the Pfizer-BioNTech vaccine against multisystem inflammatory syndrome in children ages 12-17 years. The next report looks at the risk for newly diagnosed diabetes after COVID-19 infection among children. The third report examines COVID-19 vaccination during pregnancy and its association with preterm or small-f
    January 13, 2022
    Week of December 27, 2021

    Week of December 27, 2021

    This episode discusses four MMWR reports. This first report looks at an Omicron variant cluster among a single household in Nebraska. The next report looks at vaccine safety in children ages 5-11 years. The third report examines the effectiveness of the Pfizer-BioNTech vaccine in preventing infection among adolescents ages 12-17 years. And the last report describes the characteristics and clinical
    January 5, 2022
    Week of December 13, 2021

    Week of December 13, 2021

    This episode discusses five MMWR reports. This first report looks at the impact of a health care provider recommendation on vaccination status and attitudes among adults. The next two reports explore a testing strategy among k-12 schools in Los Angeles County, California and Lake County, Illinois. And the last two describe cases of a rare fungal infection reported by clinicians in Honduras and Ark
    December 22, 2021
    Week of November 1, 2021

    Week of November 1, 2021

    This episode discusses two MMWR reports. The first highlights ACIP's interim recommendation for the use of the Pfizer-BioNTech COVID-19 Vaccine in children ages 5-11 years. And the second looks at the effectiveness of mRNA vaccination among immunocompromised and immunocompetent adults.
    November 10, 2021
    Week of September 13, 2021

    Week of September 13, 2021

    This episode discusses six MMWR COVID-19 reports. TThe first three reports look at the effectiveness of COVID-19 vaccines, including during the rise of the Delta variant. The fourth report highlights how untreated wastewater is being used to detect community infection trends. The next report describes the frequency of long-term symptoms of COVID-19, and the last report looks at a modified quaranti
    September 14, 2021
    Week of September 6, 2021

    Week of September 6, 2021

    This episode discusses six MMWR COVID-19 reports. The first report looks at a heart complication that COVID-19 patients are at higher risk of developing. The next two highlight the increase in emergency department visits and hospitalizations among children and adolescents. The next two reports describe a testing program at the University of Texas at Austin and an outbreak following Spring Break 20
    September 14, 2021
    Week of August 16, 2021

    Week of August 16, 2021

    This episode discusses five MMWR COVID-19 reports. The first three reports highlight the effectiveness of COVID-19 vaccines against infection and hospitalization among adults and nursing home residents. The fourth report describes how there were many more deaths than usual in 2020 and how people from racial and ethnic minority groups were disproportionately affected. The last report shows how rap
    August 24, 2021
    Week of August 9, 2021

    Week of August 9, 2021

    This episode discusses two MMWR COVID-19 reports. The first report highlights the benefits of all three FDA-authorized COVID-19 vaccines in preventing COVID-19 infections and hospitalizations. The second report explores alternative methods for analyzing race and ethnicity data for COVID-19 cases and vaccinations.
    August 17, 2021
    Week of May 10, 2021

    Week of May 10, 2021

    This episode discusses five MMWR COVID-19 reports. The first report provides more evidence that mRNA COVID-19 vaccines are effective in real-world conditions. The second report describes how nearly 80% of people 65 years and older received at least one dose of COVID-19 vaccine. The third report describes the Advisory Committee on Immunization Practices' recommendation for use of the Pfizer-BioNTec
    May 18, 2021
    Week of May 3, 2021

    Week of May 3, 2021

    This episode discusses three MMWR COVID-19 reports. The first report projects how increasing vaccination coverage and the use of preventive measures will affect new COVID-19 cases. Two other reports describe the identification of COVID-19 variants in the United States.
    May 11, 2021
    Week of April 26, 2021

    Week of April 26, 2021

    This episode discusses seven MMWR COVID-19 reports. The first report provides an update on the Advisory Committee on Immunization Practices recommendations for Johnson & Johnson's Janssen COVID-19 vaccine. The next two reports are about safety monitoring of the Janssen vaccine. Next is a report on an evaluation of the benefits of mRNA COVID-19 vaccines against hospitalization. Two reports detail C
    May 6, 2021
    Week of April 19, 2021

    Week of April 19, 2021

    This episode discusses five MMWR COVID-19 reports. Two reports show that COVID-19 vaccination was effective in preventing illness among residents and staff in skilled nursing facilities. Another is about post-COVID conditions among adults with COVID-19 who did not require a hospital stay. The fourth highlights how Alaska's testing and quarantine requirements for air travelers may have reduced COVI
    April 28, 2021
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.